| Product Code: ETC6184531 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Mandibular Advancement Devices (MADs) market in Australia is witnessing consistent growth, primarily driven by increasing awareness around sleep disorders such as obstructive sleep apnea (OSA). As the prevalence of OSA continues to rise among Australians, there is growing demand for non-invasive and cost-effective treatment options like MADs. These devices, which reposition the jaw to maintain open airways during sleep, are gaining popularity over surgical and CPAP alternatives due to their user-friendliness and portability. Innovation in device materials and customization options is enhancing patient comfort and compliance, further encouraging adoption. The market is also supported by an increase in sleep clinics and diagnostic facilities across the country. Regulatory support and insurance coverage for sleep-related devices are also helping to expand market reach. Looking ahead, technological advancements and increased collaboration between dentists and sleep specialists are expected to propel the market forward.
The mandibular advancement devices (MADs) market in Australia is expanding as awareness about sleep disorders, particularly obstructive sleep apnea (OSA), grows. MADs are oral devices used to treat snoring and mild to moderate sleep apnea by repositioning the lower jaw to open the airway. As the prevalence of sleep apnea and related conditions continues to rise, particularly among older adults and individuals with obesity, the demand for non-invasive treatment options such as MADs is increasing. These devices offer a comfortable and convenient alternative to continuous positive airway pressure (CPAP) therapy, which some patients find difficult to use. The growing number of sleep disorder clinics and advancements in dental technology are also contributing to the market`s growth. As Australians seek more effective and affordable treatments for sleep-related issues, the mandibular advancement devices market is expected to continue to grow.
The mandibular advancement devices (MADs) market in Australia faces several challenges related to consumer acceptance and treatment effectiveness. MADs are commonly used for treating obstructive sleep apnea (OSA) and snoring by repositioning the lower jaw to keep the airway open. However, patient compliance is a significant issue, as many individuals find the devices uncomfortable to wear, especially for prolonged periods. The market also faces competition from other treatments such as continuous positive airway pressure (CPAP) therapy, which may be seen as more effective by healthcare providers and patients. Additionally, the customization of MADs, necessary for optimal fit and comfort, can make them costly, limiting accessibility for some patients. There are also concerns about long-term usage, as poorly fitted devices can cause dental or jaw problems. Furthermore, limited awareness about MADs in the general population, coupled with the availability of other treatments, can hinder their adoption. The regulatory framework for dental devices also adds an additional layer of complexity in terms of approval and compliance.
The mandibular advancement devices market in Australia is witnessing growth due to the rising incidence of sleep apnea and other sleep-related disorders. These devices, designed to reposition the lower jaw during sleep, are an effective treatment for obstructive sleep apnea (OSA), a condition that affects a significant portion of the population. As awareness about the health risks associated with untreated sleep apnea, such as heart disease and stroke, increases, more individuals are seeking non-invasive treatment options. Additionally, the growing trend towards at-home sleep apnea treatment solutions, including mandibular advancement devices, is contributing to market growth. The market also benefits from advancements in device comfort, customization, and ease of use, which are improving patient compliance. This presents investment opportunities in the development and marketing of innovative mandibular advancement devices designed to address the needs of a broader consumer base.
The Australian government regulates mandibular advancement devices (MADs), commonly used to treat sleep apnea and snoring, to ensure their safety and effectiveness. The Therapeutic Goods Administration (TGA) classifies MADs as medical devices, requiring manufacturers to obtain appropriate approvals before marketing. Devices must comply with the Essential Principles outlined in the Therapeutic Goods (Medical Devices) Regulations 2002, which include standards for design, manufacturing, and clinical evidence. Healthcare providers are guided by clinical practice guidelines developed by the National Health and Medical Research Council (NHMRC) for the prescription and use of MADs. The government also supports research into sleep disorders to inform policy and improve treatment options. These regulatory frameworks aim to ensure patient safety and the efficacy of treatments involving MADs.?
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Mandibular Advancement Devices Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Mandibular Advancement Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Mandibular Advancement Devices Market - Industry Life Cycle |
3.4 Australia Mandibular Advancement Devices Market - Porter's Five Forces |
3.5 Australia Mandibular Advancement Devices Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Australia Mandibular Advancement Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Australia Mandibular Advancement Devices Market Revenues & Volume Share, By Material Type, 2021 & 2031F |
3.8 Australia Mandibular Advancement Devices Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Mandibular Advancement Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about sleep apnea and related disorders in Australia |
4.2.2 Rising prevalence of snoring and sleep-related breathing issues |
4.2.3 Growing demand for non-invasive treatment options for sleep disorders |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for mandibular advancement devices in Australia |
4.3.2 Lack of skilled professionals for accurate diagnosis and prescription of mandibular advancement devices |
5 Australia Mandibular Advancement Devices Market Trends |
6 Australia Mandibular Advancement Devices Market, By Types |
6.1 Australia Mandibular Advancement Devices Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Australia Mandibular Advancement Devices Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Australia Mandibular Advancement Devices Market Revenues & Volume, By Bite MAD, 2021- 2031F |
6.1.4 Australia Mandibular Advancement Devices Market Revenues & Volume, By Custom MAD, 2021- 2031F |
6.1.5 Australia Mandibular Advancement Devices Market Revenues & Volume, By Semi-Custom MAD, 2021- 2031F |
6.2 Australia Mandibular Advancement Devices Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Mandibular Advancement Devices Market Revenues & Volume, By Snoring, 2021- 2031F |
6.2.3 Australia Mandibular Advancement Devices Market Revenues & Volume, By Obstructive Sleep Apnea, 2021- 2031F |
6.2.4 Australia Mandibular Advancement Devices Market Revenues & Volume, By Temporomandibular Joint Syndrome, 2021- 2031F |
6.3 Australia Mandibular Advancement Devices Market, By Material Type |
6.3.1 Overview and Analysis |
6.3.2 Australia Mandibular Advancement Devices Market Revenues & Volume, By Metal, 2021- 2031F |
6.3.3 Australia Mandibular Advancement Devices Market Revenues & Volume, By Plastic, 2021- 2031F |
6.4 Australia Mandibular Advancement Devices Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Australia Mandibular Advancement Devices Market Revenues & Volume, By Hospitals Pharmacies, 2021- 2031F |
6.4.3 Australia Mandibular Advancement Devices Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Australia Mandibular Advancement Devices Market Revenues & Volume, By Online Stores, 2021- 2031F |
7 Australia Mandibular Advancement Devices Market Import-Export Trade Statistics |
7.1 Australia Mandibular Advancement Devices Market Export to Major Countries |
7.2 Australia Mandibular Advancement Devices Market Imports from Major Countries |
8 Australia Mandibular Advancement Devices Market Key Performance Indicators |
8.1 Number of sleep clinics offering mandibular advancement devices in Australia |
8.2 Patient adherence rate to mandibular advancement devices therapy |
8.3 Percentage of healthcare providers trained in the prescription and fitting of mandibular advancement devices |
9 Australia Mandibular Advancement Devices Market - Opportunity Assessment |
9.1 Australia Mandibular Advancement Devices Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Australia Mandibular Advancement Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Australia Mandibular Advancement Devices Market Opportunity Assessment, By Material Type, 2021 & 2031F |
9.4 Australia Mandibular Advancement Devices Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Mandibular Advancement Devices Market - Competitive Landscape |
10.1 Australia Mandibular Advancement Devices Market Revenue Share, By Companies, 2024 |
10.2 Australia Mandibular Advancement Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here